These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9143604)

  • 1. Upregulation of urokinase-type plasminogen activator by endogenous and exogenous HIV-1 Tat protein in tumour cell lines derived from BK virus/tat-transgenic mice.
    Rusnati M; Coltrini D; Campioni D; Tanghetti E; Corallini A; Barbanti-Brodano G; Giuliani R; Gibellini D; Presta M
    AIDS; 1997 May; 11(6):727-36. PubMed ID: 9143604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promotion of tumour metastases and induction of angiogenesis by native HIV-1 Tat protein from BK virus/tat transgenic mice.
    Corallini A; Campioni D; Rossi C; Albini A; Possati L; Rusnati M; Gazzanelli G; Benelli R; Masiello L; Sparacciari V; Presta M; Mannello F; Fontanini G; Barbanti-Brodano G
    AIDS; 1996 Jun; 10(7):701-10. PubMed ID: 8805860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombospondin-1/HIV-1 tat protein interaction: modulation of the biological activity of extracellular Tat.
    Rusnati M; Taraboletti G; Urbinati C; Tulipano G; Giuliani R; Molinari-Tosatti MP; Sennino B; Giacca M; Tyagi M; Albini A; Noonan D; Giavazzi R; Presta M
    FASEB J; 2000 Oct; 14(13):1917-30. PubMed ID: 11023976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity.
    Zauli G; La Placa M; Vignoli M; Re MC; Gibellini D; Furlini G; Milani D; Marchisio M; Mazzoni M; Capitani S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):306-16. PubMed ID: 7552492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B.
    Negrini M; Rimessi P; Sabbioni S; Caputo A; Balboni PG; Gualandri R; Manservigi R; Grossi MP; Barbanti-Brodano G
    Biotechniques; 1991 Mar; 10(3):344-53. PubMed ID: 1829615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size.
    Rusnati M; Coltrini D; Oreste P; Zoppetti G; Albini A; Noonan D; d'Adda di Fagagna F; Giacca M; Presta M
    J Biol Chem; 1997 Apr; 272(17):11313-20. PubMed ID: 9111037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine augmentation of HIV-1 LTR-driven gene expression in neural cells.
    Swingler S; Easton A; Morris A
    AIDS Res Hum Retroviruses; 1992 Apr; 8(4):487-93. PubMed ID: 1599755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonists.
    Rusnati M; Tulipano G; Urbinati C; Tanghetti E; Giuliani R; Giacca M; Ciomei M; Corallini A; Presta M
    J Biol Chem; 1998 Jun; 273(26):16027-37. PubMed ID: 9632653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of c-Fos in activated T lymphoid and monocytic cells by human immunodeficiency virus-1 Tat protein.
    Gibellini D; Caputo A; Capitani S; La Placa M; Zauli G
    Blood; 1997 Mar; 89(5):1654-64. PubMed ID: 9057648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
    Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
    Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of insulin-like growth factor I on HIV type 1 long terminal repeat-driven chloramphenicol acetyltransferase expression.
    Germinario RJ; Colby-Germinario SP; Acel A; Chandok R; Davison K; Mak J; Kleiman L; Faust E; Wainberg MA
    AIDS Res Hum Retroviruses; 1999 Jun; 15(9):829-36. PubMed ID: 10381171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential.
    Lockwood CJ; Krikun G; Aigner S; Schatz F
    J Clin Endocrinol Metab; 1996 Jan; 81(1):107-12. PubMed ID: 8550736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A sensitive promoter assay based on the transcriptional activator Tat of the HIV-1 virus.
    Koken SE; van Wamel J; Berkhout B
    Gene; 1994 Jul; 144(2):243-7. PubMed ID: 8039709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein.
    Scala G; Ruocco MR; Ambrosino C; Mallardo M; Giordano V; Baldassarre F; Dragonetti E; Quinto I; Venuta S
    J Exp Med; 1994 Mar; 179(3):961-71. PubMed ID: 8113688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular factors regulate transactivation of human immunodeficiency virus type 1.
    Barry PA; Pratt-Lowe E; Unger RE; Luciw PA
    J Virol; 1991 Mar; 65(3):1392-9. PubMed ID: 1995949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus type 1 Tat and methamphetamine affect the release and activation of matrix-degrading proteinases.
    Conant K; St Hillaire C; Anderson C; Galey D; Wang J; Nath A
    J Neurovirol; 2004 Feb; 10(1):21-8. PubMed ID: 14982725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Her-2/neu and urokinase-type plasminogen activator and its inhibitor in breast cancer.
    Konecny G; Untch M; Arboleda J; Wilson C; Kahlert S; Boettcher B; Felber M; Beryt M; Lude S; Hepp H; Slamon D; Pegram M
    Clin Cancer Res; 2001 Aug; 7(8):2448-57. PubMed ID: 11489825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication of HIV type 1 in rabbit cell lines is not limited by deficiencies in tat, rev, or long terminal repeat function.
    Cho S; Kindt TJ; Zhao TM; Sawasdikosol S; Hague BF
    AIDS Res Hum Retroviruses; 1995 Dec; 11(12):1487-93. PubMed ID: 8679293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor type-2 (PAI-2) in human keratinocytes regulates pericellular urokinase-type plasminogen activator.
    Reinartz J; Schaefer B; Bechtel MJ; Kramer MD
    Exp Cell Res; 1996 Feb; 223(1):91-101. PubMed ID: 8635500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.